Chronic inflammation, another hallmark of cancer, is related to almost 20% of human cancers by enabling oncogenic mutations and creating a tumor-promoting microenvironment through the activation of inflammatory signaling pathways, such as NF-κB and MAPKs. The gene discussed is NFKB1; the disease is cancer.